NuScale's Promotional Article Clashes with Financing Overhang Realities

What happened

A Motley Fool article published on March 29, 2026, argues that NuScale Power's stock is a buy under $20, highlighting its NRC-approved SMR and deployment efforts with TVA and others. However, the latest DeepValue report reveals that the equity's near-term value is dominated by financing overhangs, not technological milestones, with the stock trading at $11.43. NuScale faces significant cash commitments, including $259.9 million due in 2026 from ENTRA1 milestones, and has a new $1 billion ATM program that risks substantial dilution to fund operations. Additionally, Fluor's ongoing sell-down of 40 million shares creates persistent secondary supply pressure, capping price rallies despite any positive news flow. Thus, while the article paints a rosy long-term picture, immediate investor focus must remain on liquidity management and share supply dynamics.

Implication

The bullish case in the article overlooks the near-term financial strains detailed in filings, such as $397.976 million in 2026 commitments and $459.6 million in FY2025 operating cash use. Dilution from the ATM program and Fluor's trading program could erode per-share value even if deployment progresses, as share supply remains a primary return driver. Key catalysts for a rating upgrade include clarity on deferring the $259.9 million 2026 payable and evidence of non-dilutive funding or Romania implementation steps. Without these developments, the stock may stay pressured by overhangs, limiting upside despite long-term potential. Therefore, maintaining a WAIT stance is prudent until financing de-risks, with re-assessment in 3-6 months based on ATM activity and milestone updates.

Thesis delta

The Motley Fool article promotes a long-term buy thesis but does not address the critical near-term financing overhangs identified in the DeepValue report, such as dilution risks and cash timing pressures. Therefore, the investment thesis remains unchanged: SMR is a WAIT until dilution from ATM usage and Fluor sales is mitigated or cash commitments are deferred, with no shift in the base case valuation of $13.